News Detail | Mallinckrodt Pharmaceuticals
P3 acquires 233,000 sq. ft. pharma HQ building in Bedminster, C&W says – Real Estate NJ
Mallinckrodt - Wikipedia
Mallinckrodt Jobs in October, 2022 (Hiring Now!)
New Jersey | Mallinckrodt Pharmaceuticals
Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students
Jon Green - Director of Regulatory Affairs Compliance and Licensing at Mallinckrodt Pharmaceuticals - Bedminster, New Jersey, United States | LinkedIn
News : Shelbourne
Mallinckrodt Pharmaceuticals | LinkedIn
The 2 pharmaceutical giants coming to Central Jersey - nj.com
Mallinckrodt Pharmaceuticals Opens Bedminster Office, Adds 330 New Jobs | Bernardsville, NJ Patch
NJBIA, New Jersey Business Magazine Recognize Mallinckrodt Pharmaceuticals Among Outstanding Redevelopment Projects - Mallinckrodt Pharmaceuticals Blog
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC | Business Wire
Turner Construction Company New Jersey - #Turner partnered with Mallinckrodt Pharmaceuticals to fit-out their 155,000 sq. ft. regional office in Bedminster, NJ, which accommodates over 400 employees. #BuiltByTurner #Commercial #Office #Renovation @MNK ...
New Jersey | Mallinckrodt Pharmaceuticals
Mallinckrodt, ensnared in opioid crisis, seeks Chapter 11 | WCIV
Kimberly Arnold - Scientific Affairs Manager at Mallinckrodt Pharmaceuticals - Bedminster, New Jersey, United States | LinkedIn
Pharma Maker Mallinckrodt Returns Its US Headquarters to Hunterdon County, New Jersey
Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit | Fierce Pharma
AT&T relocating employees in Bedminster | Bernardsville News News | newjerseyhills.com
St. Louis, MO | Mallinckrodt Pharmaceuticals
NJ Announces Mallinckrodt to Pay More Than $230M For Alleging Underpayment of Medicaid Drug Rebates
New Jersey | Mallinckrodt Pharmaceuticals
Mallinckrodt to Buy Sucampo Pharmaceuticals for About $840 Million - WSJ
